The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434)

ConclusionEpacadostat in combination with pembrolizumab was generally safe and well tolerated among Japanese patients with advanced solid tumors.Clinical trial registration NCT02862457.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research